These findings align with previous research demonstrating the therapeutic potential of natural products like Cinnamaldehyde, Sarsasapogenin-AA13, Ginkgo biloba extracts, and active components of Andrographis paniculata in targeting these pathways for AD treatment [49, 89,90,91,92]
ABR threshohlds were determined 3 days post-treatment at various frequencies (4, 10, 14, and 20 kHz)
These movements contribute to degeneration over time
The Bottom Line Although AOD-9604, MOTS-c, Tesamorelin, Semaglutide, and Tirzepatide are often discussed together, they serve very different purposes
Peptide solutions are much less stable than powders
Therapy frequency, dosing, and duration are shaped by patient-specific factors, allowing results to be evaluated within a realistic and medically informed framework